Cue Biopharma, Inc.
CUE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645460
In the last 90 days, Cue Biopharma, Inc. insiders filed 0 open-market purchases and 3 sales; 50 institutions reported holding it in 13F filings for Q2 2026, worth $52.2M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Cue Biopharma, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 55 | 49 | −6 |
| Shares | 11.8M | 11.4M | −356.8K (−3.0%) |
| Value | $12.8M | $10.4M | −$2.44M (−19.1%) |
New holders (7)
Institutions that held Cue Biopharma, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Chicago Partners Investment Group LLC | 90,302 | $69.4K | 0.00% |
| Renaissance Technologies LLC | 36,946 | $33.7K | 0.00% |
| StoneX Group Inc. | 14,058 | $12.8K | 0.00% |
| Group One Trading, L.P. | 13,572 | $12.4K | 0.00% |
| Two Sigma Securities, LLC | 10,390 | $9.46K | 0.00% |
| Tidemark, LLC | 1,500 | $1.37K | 0.00% |
| Mather Group, LLC. | 1,000 | $911 | 0.00% |
Sold out (13)
Institutions that held Cue Biopharma, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Good Life Advisors, LLC | 400,000 | $436.0K |
| Millennium Management LLC | 69,295 | $75.5K |
| Jane Street Group, LLC | 63,767 | $69.5K |
| HRT Financial LP | 49,055 | $53.0K |
| Point72 Asia (Singapore) Pte. Ltd. | 27,764 | $30.3K |
| Virtu Financial LLC | 16,829 | $18.0K |
| Susquehanna International Group, LLP | 13,258 | $14.5K |
| Cubist Systematic Strategies, LLC | 3,661 | $3.99K |
| Larson Financial Group LLC | 1,400 | $1.53K |
| FMR LLC | 96 | $105 |
| Point72 (DIFC) Ltd | 66 | $72 |
| Citigroup Inc | 43 | $47 |
| SBI Securities Co., Ltd. | 1 | $1 |